Implementation Research on Telehealth Strategies to Support Retention in Care and Treatment among Antiretroviral Therapy (ART) Patients and Pre-exposure Prophylaxis (PrEP) Clients

The summary for the Implementation Research on Telehealth Strategies to Support Retention in Care and Treatment among Antiretroviral Therapy (ART) Patients and Pre-exposure Prophylaxis (PrEP) Clients grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.

Implementation Research on Telehealth Strategies to Support Retention in Care and Treatment among Antiretroviral Therapy (ART) Patients and Pre-exposure Prophylaxis (PrEP) Clients: The purpose of this notice of funding opportunity (NOFO) is to solicit research applications to evaluate the effectiveness of telemedicine to improve adherence to HIV prevention and treatment medication while also exploring the “implementability” of its practice into routine care. Specifically, this NOFO will, via a hybrid effectiveness-implementation research design: 1) evaluate the effectiveness of telemedicine and supportive strategies to allow for retention in care and maintenance of antiretroviral therapy (ART) medication adherence among clinically stable people with HIV (PWH) and pre-exposure prophylaxis (PrEP) medication adherence among those at risk for HIV infection, especially among racial/ethnic minorities, men who have sex with men (MSM), and transgender women and 2) identify potential implementation challenges by evaluating the delivery of these strategies. Projects should evaluate the cost-effectiveness of providing differentiated service delivery (DSD) options that include telemedicine to patients on ART or on PrEP. DSD is a recommended approach to service delivery that simplifies and/or adapts HIV prevention and treatment services to more effectively and efficiently serve the needs of people living with, and at risk of acquiring, HIV while reducing unnecessary burdens on the healthcare system. The goals of the research are: 1) to evaluate three recommended strategies for DSD for clinically stable patients (a. telehealth appointments for PrEP and ART with multi-month prescription refills; b. biospecimen sample self-collection for routine screenings; and c. supplemental support delivered by specialized staff such as community health workers or patient navigators); 2) to determine which strategy or combination of strategies is associated with retention in care, medication adherence, viral suppression and prevention of HIV infection, and costs to implement each approach; 3) to evaluate the cost effectiveness of implementing these strategies in comparison to the standard, in-person clinical visit model of care; and 4) to identify potential challenges to implementation and determine the acceptability, feasibility and sustainability of implementing these strategies into routine practice. Ultimately, this NOFO aims to support research to identify, via cost analysis, process and outcome evaluation and patient and provider feedback, which elements of implementation provide the most impact for the least cost to patients, providers, and clinics.

Federal Grant Title:	Implementation Research on Telehealth Strategies to Support Retention in Care and Treatment among Antiretroviral Therapy (ART) Patients and Pre-exposure Prophylaxis (PrEP) Clients
Federal Agency Name:	Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-PS-22-002
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.941
CFDA Descriptions:	Information not provided
Current Application Deadline:	February 1st, 2022
Original Application Deadline:	February 1st, 2022
Posted Date:	November 6th, 2021
Creation Date:	November 6th, 2021
Archive Date:	March 3rd, 2022
Total Program Funding:	$3,600,000
Maximum Federal Grant Award:	$450,000
Minimum Federal Grant Award:	$400,000
Expected Number of Awards:	2
Cost Sharing or Matching:	No
Last Updated:	January 27th, 2022

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: The following types of Higher Education Institutions are always encouraged to apply for CDC support as Non-profit Public or Non-profit Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits (Other than Institutions of Higher Education) Private non-profit institutions of higher education Eligible Agencies of the Federal Government U.S. Territory or Possession Faith-based or Community-based Organizations Regional Organizations Bona Fide Agents: a Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via https://www.grants.gov Federally Funded Research and Development Centers (FFRDCs): FFRDCs are operated, managed, and/or administered by a university or consortium of universities, other not-for-profit or nonprofit organization, or an industrial firm, as an autonomous organization or as an identifiable separate operating unit of a parent organization. A FFRDC meets some special long-term research or development need which cannot be met as effectively by an agency's existing in-house or contractor resources. FFRDC's enable agencies to use private sector resources to accomplish tasks that are integral to the mission and operation of the sponsoring agency. For more information on FFRDCs, go to https://ecfr.io or https://www.nsf.gov/statistics/ffrdclist/
Grant Announcement Contact: Jocelyn Patterson Mosley
[email protected]
[email protected]
Similar Government Grants: • Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works i...; • Minority HIV Research Initiative (MARI): Epidemiologic, Behavioral, and Implementation Sci...; • Increasing PrEP Use Among Disproportionately Affected Populations in the United States; • PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices; • Evaluation of New HIV Testing Technologies in Clinical Settings with High HIV Incidence; • Diffusion of Partnership for Health to Health Care and Medical Agencies Serving Persons Li...; • Translating Proven Interventions for Underserved and Emergent High-Risk Populations (REP 7...; • Evaluation of the Relative Effectiveness of Four Public Health Strategies for Providing HI...
More Grants from the Centers for Disease Control and Prevention ERA: • Rigorously Evaluating Primary Prevention Strategies for Intimate Partner Violence and Sexu...; • Formative Research of Community-led Primary Prevention Approaches to Address Elevated Risk...; • Rigorous Evaluation of Primary and Secondary Overdose Prevention Activities Among Populati...; • Effectiveness Research to Prevent Polysubstance-Impaired Driving; • Grants to Support New Investigators in Conducting Research Related to Preventing Interpers...